BACKGROUND while numerous ordinances on drug pricing and reimbursement have been enacted, trying to suppress the drug expenditure in Croatia, it seemed there were inconsistencies in pricing procedures of some of the drugs. OBJECTIVES to show whether or not the pricing system given has had the desired result, we review pricing and reimbursement systems of generics in some of the EU countries a...

The number o f Japanese firms in Brussels has increased since the creation o f the European Single Market. At the same time, large European firms have become independent political actors and harmonized their lobbying pattern, creating a distinctive business-govemment relationship in the EU. Yet, it still remains to be examined whether Japanese firms are able to utilize their political options a...

Since the 1980s biotechnology has been promoted as a symbol of European progress. As a clean technology, agbiotech was meant to enhance efficient agri-production and thus fulfil the beneficent promise of a European Biosociety, like its counterpart of the Information Society. By the early 1990s biotech symbolised the ‘knowledge-based society’ and eventually the Lisbon agenda. At the 2000 Lisbon ...

This publication has been produced with the assistance of the European Union. The contents of this publication are the sole responsibility of ECRAN and can in no way be taken to reflect the views of the European Union.

The aim of this paper is to describe the development of a new education programme in public health for nurses in the European Union (EU). The project, 'Development of a Continuous Professional Education Programme for Nurses in Public Health', is described together with its background and aim, which is to contribute to the development of new competencies of nurses in nursing and public health. F...

2 Executive summary 3